Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Andersen s disease

Type IV Amylopectinosis, Andersen s disease Absence of branching enzyme Accumulation of a polysaccharide having few branch points. Death due to cardiac or liver failure in first year of life. [Pg.152]

IV Glycogen-branching enzyme Andersen s disease Failure to thrive cirrhosis and death at age 5 years... [Pg.111]

On the other side of the coin, Andersen s disease results from a genetic defect in the branching enzyme. Individuals who have this disease produce very long, unbranched glycogen chains. This genetic disorder results in decreased efficiency of glycogen storage. [Pg.654]

IV Andersen s disease Brandling enzyme Abnormally long iinbrandied diains Liver and odier organs... [Pg.643]

Deficiency of the enzyme causes the severe, and usually fatal, Andersen s disease (see here). Structure of glycogen in these individuals is abnormal - long chains of glucose with very few branches. [Pg.644]

Cori type IV G.s.d. (Andersen s disease, Amylopec-linosis). [Pg.259]

Andersen OM, Willnow TE (2006) Lipoprotein receptors in Alzheimer s disease. Trends Neurosci 29 687-694... [Pg.708]

Carbohydrate abnormalities, such as renal glycosuria (a transport defect), pentosuria (enzyme deficiency, xylitol dehydrogenase I. lactase deficiencies, fructose intolerance, galactosemia, galacloki-nase deficiency, oxalosis, and several glycogenoses (von Gierke s, Forbes . Andersen s, Hers s. and Tarui s diseases). [Pg.716]

Laurberg P, Bulow Pedersen I, Knudsen N, Ovesen L, Andersen S. Environmental iodine intake affects the type of nonmalignant thyroid disease. Thyroid 2001 ll(5) 457-69. [Pg.322]

Bharath S, Hsu M, Kaur D, Rajagopalan S, Andersen JK. 2002. Glutathione, iron and Parkinson s disease. Biochem Pharmacol 64 1037-1048. [Pg.444]

Andersen JM, Myhre O, Fonnum F. 2003. Discussion of the role of the extracellular signal-regulated kinase-phospholipase A2 pathway in production of reactive oxygen species in Alzheimer s disease. Neurochem Res 28 319-326. [Pg.465]

Andersen K, Launer LJ, Ott A, Hoes AW, Breteler MM, Hofman A. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer s disease The Rotterdam Study. Neurology 1995 45(8) 1441-5. [Pg.2576]

Holm S, Andersen AR, Vorstrup S, Lassen NA, Paulson OB, Holmes RA (1985) Dynamic SPECT of the brain using a lipophilic technetium-99m complex, PnAO. J Nucl Med 26 1129-1134 Holman BL, Johnson KA, Gerada B, Carvalho PA, Satlin A (1992) The scintigraphic appearance of Alzheimer s disease A prospective study using technetium-99m-HM-PAO SPECT. J Nucl Med 33 181-185... [Pg.258]

Chinta, S. J., Rajagopalan, S., Ganesan, A., and Andersen, J.K. 2012. A possible novel anti-inflammatory mechanism for the pharmacological prolyl hydroxylase inhibitor 3,4-dihydroxybenzo-ate implications for use as a therapeutic for Parkinson s disease. Parkinson s Disease, 2012, 364684. doi 10.1155/2012/364684. [Pg.241]

See other pages where Andersen s disease is mentioned: [Pg.700]    [Pg.484]    [Pg.486]    [Pg.596]    [Pg.292]    [Pg.203]    [Pg.166]    [Pg.166]    [Pg.700]    [Pg.484]    [Pg.486]    [Pg.596]    [Pg.292]    [Pg.203]    [Pg.166]    [Pg.166]    [Pg.347]    [Pg.656]    [Pg.992]    [Pg.721]    [Pg.190]    [Pg.461]    [Pg.217]    [Pg.347]    [Pg.656]    [Pg.992]    [Pg.93]    [Pg.743]    [Pg.642]    [Pg.257]    [Pg.718]    [Pg.18]   
See also in sourсe #XX -- [ Pg.152 ]

See also in sourсe #XX -- [ Pg.700 , Pg.722 ]

See also in sourсe #XX -- [ Pg.596 ]

See also in sourсe #XX -- [ Pg.37 ]



SEARCH



Andersen

© 2024 chempedia.info